COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,742 Articles (22,502 medRxiv, 8,240 bioRxiv)

Most recent first Previous |  Page 1619: Articles 16181-16190  | Next

Development and Evaluation of a new Swiss Made SARS-CoV-2 antigen-detecting rapid test
Ducrest, P. J.
10.1101/2021.03.25.21252280 — Posted: 2021-03-26
Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient
Klein, J., Brito, A. F., Trubin, P., Lu, P., Wong, P., Alpert, T., Pena-Hernandez, M. A., Haynes, W., Kamath, K., Liu, F., Vogels, C. B. F., Fauver, J. R., Lucas, C., Oh, J., Mao, T., Silva, J., Wyllie, A. L., Muenker, C., Casanovas-Massana, A., Moore, A. J., Petrone, M. E., Kalinich, C. C., IMPACT Research Team, , Cruz, C. D., Farhadian, S., Ring, A., Shon, J., Ko, A. I., Grubaugh, N. D., Israelow, B., Iwasaki, A., Azar, M. M.
10.1101/2021.03.24.21253992 — Posted: 2021-03-26
Pattern of COVID-19 epidemics in Japan influenced by the control measures
Konishi, T.
10.1101/2021.03.24.21253923 — Posted: 2021-03-26 Discussion: Onsite
Tenofovir-DF versus Hydroxychloroquine in the Treatment of Hospitalized Patients with COVID-19: An Observational Study (THEDICOV)
Cornejo-Giraldo, M., Rosado, N., Salinas, J., Aspilcueta, N., Bernales, E., Lipa, J., Coacalla, J., Flores, Y., Leon, P., Chambi, C.
10.1101/2021.03.24.21252635 — Posted: 2021-03-26
Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers
Padoan, A., Dall'Olmo, L., Della Rocca, F., Barbaro, F., Cosma, C., Basso, D., Cattelan, A., Cianci, V., Plebani, M.
10.1101/2021.03.24.21254240 — Posted: 2021-03-26
Estimated Deaths, Intensive Care Admissions and Hospitalizations Averted in Canada during the COVID-19 Pandemic
Fisman, D., Tuite, A.
10.1101/2021.03.23.21253873 — Posted: 2021-03-26
Molecular beacons allow specific RT-LAMP detection of B.1.1.7 variant SARS-CoV-2
Sherrill-Mix, S., Van Duyne, G. D., Bushman, F. D.
10.1101/2021.03.25.21254356 — Posted: 2021-03-26
Importance of serological testing in the convalescence phase in patients with pulmonary impairment due to COVID 19 - a health care workers analysis
Pereira, J. R., Santoro, I. L., Santos, M. S. B., de Toledo, A. P., Capelli, G. E., de Franca, C. V. G., Caboclo, E. D. G.
10.1101/2021.03.24.20208835 — Posted: 2021-03-26
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study)
Shrotri, M., Krutikov, M., Palmer, T., Giddings, R., Azmi, B., Subbarao, S., Fuller, C., Irwin-Singer, A., Davies, D., Tut, G., Lopez Bernal, J., Moss, P., Hayward, A., Copas, A., Shallcross, L.
10.1101/2021.03.26.21254391 — Posted: 2021-03-26
Regional performance variation in external validation of four prediction models for severity of COVID-19 at hospital admission: An observational multi-centre cohort study
Wickstrom, K., Vitelli, V., Carr, E., Holten, A. R., Bendayan, R., Reiner, A. H., Bean, D., Searle, T., Shek, A., Kraljevic, Z., Teo, J. T., Dobson, R., Tonby, K., Kohn-Luque, A., Amundsen, E. K.
10.1101/2021.03.26.21254390 — Posted: 2021-03-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).